The SLAS Fellow Member Program launched in 2016 to recognize the exceptional contributions of SLAS’s most valued contributors. SLAS Fellow Members represent the epitome of SLAS as a mission-driven organization that focuses on serving life sciences professionals via practitioner-driven knowledge, education and peer-to-peer connections.
Join or renew your SLAS Premier Membership to begin your journey to becoming an SLAS Fellow Member.
*Denotes 2023 Fellows
Michelle Arkin, Ph.D.
University of California - San Francisco
Ellen Berg, Ph.D.
DiscoverX Corporation
Marc Bickle, Ph.D.
Max Planck Institute of Molecular Cell Biology and Genetics
Manuela Beil-Peter
Analytik Jena GmbH
Roger Bosse, Ph.D.
BioSignal2 Inc.
John Thomas Bradshaw, Ph.D.
Robert Campbell, Ph.D.
Twentyeight-seven Therapeutics
Anne Carpenter, Ph.D.
Broad Institute of Harvard and MIT
Taosheng Chen, Ph.D.
St. Jude Children’s Research Hospital
Edward Kai-Hua Chow, Ph.D.
National University of Singapore
Sabrina Corazza
Axxam Spa
J. Colin Cox, Ph.D.
Seer
Sue Crimmin, Ph.D.
GlaxoSmithKline
Melissa Crisp, Ph.D.
Eli Lilly and Company
Malcolm Crook, Ph.D.
Peak Analysis & Automation Ltd.
Sammy Datwani, Ph.D.
Synthego
Emilio Diez Monedero, Ph.D.
Hakim Djaballah, Ph.D.
Keren Therapeutics
Alain Donzel, Ph.D.
Scitec Research S.A.
Richard M. Eglen, Ph.D.
Corning Life Sciences
Richard Ellson, M.S.
Labcyte Inc.
Frank Fan, Ph.D.
Promega Corporation
Haian Fu, Ph.D.
Emory University
Ralph Garippa, Ph.D.
Memorial Sloan-Kettering
J. Fraser Glickman, M.S.P.H., Ph.D.
The Rockefeller University
Marcie Glicksman, Ph.D.
ORIG3N
Alexander Godfrey, Ph.D.
Automated Chemistry, National Center For Advancing Translational Sciences
Rose Gonzales, Ph.D.
Pfizer
*Maciej Grajewski
SG Papertronics B.V.
Peter Grandsard
Amgen
Clive Green, Ph.D.
AstraZeneca
Philip Gribbon, Ph.D.
Fraunhofer IME
Steven Hamilton, Ph.D
The Hamilton Consulting Group
David Herold, Ph.D., M.D.
Veterans Administration Medical Center/University of California, San Diego
Dean Ho, Ph.D.
UCLA Division of Oral Biology and Medicine and
KYAN Therapeutics
*Geoffrey Holdgate
AstraZeneca
Kamran Honarnejad, Ph.D.
Fraunhofer ITEM
Rob Howes, Ph.D.
AstraZeneca
William Janzen, Ph.D.
Ribometrix
*David Jennions, Ph.D.
GRAIL
Daniel Kamei, Ph.D.
University of California, Los Angeles
Katy Kettleborough
LifeArc
Deok-Ho Kim, Ph.D.
University of Washington
Gary Kramer, Ph.D.
Eberhard Krausz, Ph.D.
Evotec
Jörg Kutter, Ph.D.
University of Copenhagen
Jonathan A. Lee, Ph.D.
Eli Lilly and Company
Melanie Leveridge
GlaxoSmithKline
*Jan Lichtenberg
InSphero
Andreas H. Luippold, Ph.D.
Boehringer Ingelheim Pharma GmbH & Co. KG
Ricardo Macarron, Ph.D.
GlaxoSmithKline
Julio Martin, Ph.D.
Drexel University College of Medicine
Lorenz Mayr, Ph.D.
AstraZeneca
*Coleman Murray
Ferrologix
*Kristen Nailor
BioMolecular Resources (Genentech)
Andrew Napper, Ph.D.
Bristol Myers Squibb
Jonathan O'Connell, Ph.D.
Dewpoint Therapeutics
Christian Parker, Ph.D.
Novartis Institutes for BioMedical Research Inc.
David Pechter, Ph.D.
Pechter Technologies
*Oliver Peter
Isorsia Pharmaceuticals, Ltd.
Yohann Potier, Ph.D.
Tessera Therapeutics
Shalini Prasad, Ph.D.
University of Texas, Dallas
Stephen Rees, Ph.D., O.B.E.
AstraZeneca
*Mario Richter
Abbvie
Terry Riss, Ph.D.
Promega
Mark Russo, Ph.D.
Bristol Myers Squibb
Mariafrancesca Scalise, Ph.D.
University of Calabria
Louis Scampavia, Ph.D.
Scripps Research
Burkhard Schaefer
BSSN Software
Craig Schulz, Ph.D.
Amgen
Ian Shuttler, Ph.D.
Tecan
Peter Simpson, Ph.D.
Medicines Discovery Catapult
Daniel Sipes, M.S.
The Genomics Institute of the Novartis Research Foundation
*G. Sitta Sittampalam
NIH/NCATS
Timothy Spicer, Ph.D.
The Scripps Research Institute
James D. Sterling, Ph.D.
Keck Graduate Institute
Paul Taylor, M.S.
Boehringer Ingelheim Pharmaceuticals Inc.
*Kim Titus
Corning Life Sciences
Cathy Tralau-Stewart, Ph.D.
Takeda
Dana Vanderwall, Ph.D.
Bristol-Myers Squibb
*Steven P. van Helden
Pivot Park Screening Centre
Sabeth Verpoorte, Ph.D.
University of Groningen
Fabien Vincent, Ph.D.
Pfizer
Andrea Weston, Ph.D.
Pfizer
Aaron Wheeler, Ph.D.
University of Toronto
Mary Jo Wildey, Ph.D.
Merck
Jonathan Wingfield, Ph.D.
AstraZeneca
Pak Kin Wong, Ph.D.
Pennsylvania State University
Andy Zaayenga
SmarterLab
Zhenggrong Zhu, Ph.D.
Merck
To earn an invitation to become an SLAS Fellow Member, candidates must meet several prerequisites:
See the table below for engagement point values associated with content and service contributions.
In addition to well-deserved and prestigious recognition, SLAS Fellow Members receive a host of exclusive benefits:
SLAS Fellow Members are required to pay SLAS membership dues annually.
Please contact Gina Anzalone, SLAS Membership Manager, with any questions or to check your current eligibility toward becoming an SLAS Fellow Member.
5 total points, with at least one from content contribution and one from volunteer service activities, are required to earn an invitation to become an SLAS Fellow Member. Questions on your current status? Contact Mary Geismann at SLAS Headquarters.
Content – Technical Presentations (1 point per) | Content – Journal Manuscripts or Issue Guest Editor (2 points per) | Service – Volunteer Leadership (2 points per role) |
---|---|---|
|
|
Served volunteer leadership position in significant SLAS committee/ oversight entity:
|